Product Information
DEPO-PROVERA 150 MG/ML VIAL is a brand product labeled by Pharmacia & Upjohn Company LLC, priced at $50.9940 per ML under NDC 00009074630. Its NADAC has been published 323 times since Apr 23, 2014.
The High Outlier badge above means this manufacturer's average price in the medroxyprogesterone acetate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
150 mg/mL
Manufacturer
Pharmacia & Upjohn Company LLCNDC
00009074630
Classification
Brand
Dosage Form
INJECTION, SUSPENSION
Route
INTRAMUSCULAR
Last Updated
4/22/2026
Active Ingredients
MEDROXYPROGESTERONE ACETATEApproval Type
New Drug (NDA)
FDA Application
NDA020246On Market Since
10/29/1992
Pharmacological Classes
Price Statistics
The NADAC for DEPO-PROVERA 150 MG/ML VIAL has been published 323 times since Apr 23, 2014, and over the history we have for it it has declined 56.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $50.9940 per ML |
|---|---|
| All-time high | $205.3456 (Jan 16, 2019) |
| All-time low | $50.5420 (Jan 22, 2025) |
| 52-week high | $50.9940 |
| 52-week low | $50.6817 |
| Median price | $141.1075 |
| Average price | $138.0327 |
| Largest weekly change | -75.4% (Jan 22, 2025) |
| Weeks tracked | 323 |
| Tracking since | Apr 23, 2014 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 63% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DEPO-PROVERA 150 MG/ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for DEPO-PROVERA 150 MG/ML VIAL, manufactured by Pharmacia & Upjohn Company LLC, is $50.9940 per ML (NDC 00009074630), effective Jun 24, 2026.
How has the price of DEPO-PROVERA 150 MG/ML VIAL changed over time?
Over the history we have for it, the NADAC for DEPO-PROVERA 150 MG/ML VIAL has declined 56.9%. It has been tracked across 323 weekly CMS publications since Apr 23, 2014.
What are the highest and lowest recorded NADAC prices for DEPO-PROVERA 150 MG/ML VIAL?
Since Apr 23, 2014, the NADAC for DEPO-PROVERA 150 MG/ML VIAL has ranged from a low of $50.5420 (Jan 22, 2025) to a high of $205.3456 (Jan 16, 2019), with a median of $141.1075 per ML.
Are there cheaper alternatives to DEPO-PROVERA 150 MG/ML VIAL?
Yes. 3 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, MEDROXYPROGESTERONE 150 MG/ML, is $18.7597 per ML — about 63% below DEPO-PROVERA 150 MG/ML VIAL.
Who manufactures DEPO-PROVERA 150 MG/ML VIAL?
DEPO-PROVERA 150 MG/ML VIAL (NDC 00009074630) is labeled by Pharmacia & Upjohn Company LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification